May 05, 2020
Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
Mar 04, 2020
Galderma Announces an Acceleration of its Growth and Expansion Plans to Support Aesthetic Providers
Feb 28, 2020
Global Facial Injectables Market (2017 to 2025) - Featuring Advanced Dermatology, Merz & Galderma Laboratories Among Others
Feb 28, 2020
Global Facial Injectables Market (2017 to 2025) - Featuring Advanced Dermatology, Merz & Galderma Laboratories Among Others
Oct 24, 2019
Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation of Seven New Clinical Studies
Oct 09, 2019
Galderma Announces Positive Phase 2 Results for its Proprietary Liquid Formulation of an Investigational Botulinum Toxin and Approval of New State-of-the-Art Manufacturing Facility
Feb 28, 2019
Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology
Jan 23, 2019
Galderma Announces Formation of Women in Aesthetics Leadership Council
Nov 05, 2018
Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula
May 07, 2018
Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne
Oct 12, 2017
Galderma Announces FDA Approval of Restylane® Silk as the First HA Dermal Filler Approved for Injection via Cannula
Sep 07, 2017
Galderma Names Chris Chapman to Oversee Prescription Business Unit
Sep 07, 2017
Galderma Names Alisa Lask to Oversee Aesthetic & Corrective Business Unit